REMS Need To Be More Easily Modified, Attorney Says; Prior Approval Supplements Too Cumbersome

FDA could facilitate improvements to Risk Evaluation and Mitigation Strategies by giving companies some discretion to modify REMS elements, according to Hogan and Hartson partner Meredith Manning